Prakshay Pharma Private Limited

Tenofovir Alafenamide (TAF) is a medication used to treat HIV (Human Immunodeficiency Virus) infection and chronic hepatitis B. It is a newer version of tenofovir, an antiretroviral drug. TAF is included in combination therapies for HIV and is generally preferred over the older version, Tenofovir Disoproxil Fumarate (TDF), due to its improved safety profile and lower risk of kidney and bone problems.

TAF works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of the HIV virus. By blocking this enzyme, it helps reduce the viral load in the body and prevents the progression of HIV.

Biktarvy is a prescription medication that is commonly used for the treatment of HIV (Human Immunodeficiency Virus). It is a combination medication that includes the active ingredients:

• Bictegravir (a type of integrase strand transfer inhibitor)

• Emtricitabine (a nucleoside reverse transcriptase inhibitor, NRTI)

• Tenofovir alafenamide (another NRTI)

However, Biktarvy typically comes in a tablet form that contains 50 mg of bictegravir, 200 mg of emtricitabine, and 25 mg of tenofovir alafenamide per tablet, which is the standard dosage. A 30 mg tablet might be a misinterpretation, as the typical dosage does not include a 30 mg strength.

It's important to follow your healthcare provider's instructions about the dosage and to discuss any questions or concerns regarding the use of Biktarvy with them. If you have specific questions about your medication or dosage, it's always best to reach out to your doctor or pharmacist for clarification.